Charles Schwab’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-459,105
| Closed | -$39M | – | 3278 |
|
|
2019
Q4 | $39M | Buy |
459,105
+10,086
| +2% | +$673K | 0.02% | 778 |
|
|
2019
Q3 | $22.5M | Buy |
449,019
+55,037
| +14% | +$2.2M | 0.01% | 1061 |
|
|
2019
Q2 | $14.4M | Buy |
393,982
+11,207
| +3% | +$366K | 0.01% | 1376 |
|
|
2019
Q1 | $10.7M | Buy |
382,775
+19,064
| +5% | +$449K | 0.01% | 1548 |
|
|
2018
Q4 | $6.96M | Sell |
363,711
-1,770
| -0.5% | -$41.2K | 0.01% | 1702 |
|
|
2018
Q3 | $10.9M | Buy |
365,481
+22,007
| +6% | +$829K | 0.01% | 1577 |
|
|
2018
Q2 | $12.6M | Buy |
343,474
+6,830
| +2% | +$222K | 0.01% | 1436 |
|
|
2018
Q1 | $11.1M | Buy |
336,644
+18,182
| +6% | +$568K | 0.01% | 1422 |
|
|
2017
Q4 | $8.71M | Buy |
318,462
+16,923
| +6% | +$521K | 0.01% | 1575 |
|
|
2017
Q3 | $11.2M | Sell |
301,539
-989
| -0.3% | -$36.5K | 0.01% | 1344 |
|
|
2017
Q2 | $11.5M | Buy |
302,528
+8,900
| +3% | +$396K | 0.01% | 1243 |
|
|
2017
Q1 | $14.4M | Buy |
293,628
+678
| +0.2% | +$30.9K | 0.01% | 1057 |
|
|
2016
Q4 | $9.94M | Buy |
292,950
+14,429
| +5% | +$512K | 0.01% | 1256 |
|
|
2016
Q3 | $10.5M | Buy |
278,521
+12,188
| +5% | +$459K | 0.01% | 1137 |
|
|
2016
Q2 | $8.96M | Buy |
266,333
+17,079
| +7% | +$602K | 0.01% | 1155 |
|
|
2016
Q1 | $7.92M | Buy |
249,254
+29,820
| +14% | +$974K | 0.01% | 1206 |
|
|
2015
Q4 | $8.19M | Buy |
219,434
+10,466
| +5% | +$396K | 0.01% | 1152 |
|
|
2015
Q3 | $7.93M | Sell |
208,968
-329,180
| -61% | -$11.6M | 0.01% | 1142 |
|
|
2015
Q2 | $15.4M | Buy |
538,148
+197,667
| +58% | +$5.51M | 0.02% | 712 |
|
|
2015
Q1 | $9.54M | Buy |
340,481
+105,880
| +45% | +$2.97M | 0.01% | 1024 |
|
|
2014
Q4 | $6.49M | Sell |
234,601
-105,919
| -31% | -$2.62M | 0.01% | 1238 |
|
|
2014
Q3 | $7.6M | Buy |
340,520
+23,532
| +7% | +$598K | 0.01% | 1024 |
|
|
2014
Q2 | $9.21M | Buy |
316,988
+44,068
| +16% | +$1.18M | 0.02% | 907 |
|
|
2014
Q1 | $7.76M | Buy |
272,920
+101,744
| +59% | +$3.37M | 0.01% | 993 |
|
|
2013
Q4 | $6.61M | Buy |
171,176
+9,242
| +6% | +$330K | 0.01% | 1038 |
|
|
2013
Q3 | $5.55M | Buy |
161,934
+32,222
| +25% | +$1.03M | 0.01% | 1087 |
|
|
2013
Q2 | $4.09M | Buy |
+129,712
| New | +$4.34M | 0.01% | 1231 |
|
Other funds holding MDCO
Charles Schwab's MDCO Position: Q1 2020 in Review
Charles Schwab sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 459,105 shares — an estimated $39M sold.
Charles Schwab first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $39M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Charles Schwab reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Charles Schwab sold 459,105 Medicines Co shares in Q1 2020, an estimated $39M.
- Charles Schwab first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Charles Schwab's Medicines Co position peaked at $39M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Charles Schwab's 13F filing for Q1 2020, filed 15 May 2020.